Literature DB >> 24497660

Monthly fluctuations of insomnia symptoms in a population-based sample.

Charles M Morin1, M Leblanc1, H Ivers1, L Bélanger1, Chantal Mérette1, Josée Savard1, Denise C Jarrin1.   

Abstract

STUDY
OBJECTIVES: To document the monthly changes in sleep/insomnia status over a 12-month period; to determine the optimal time intervals to reliably capture new incident cases and recurrent episodes of insomnia and the likelihood of its persistence over time.
DESIGN: Participants were 100 adults (mean age = 49.9 years; 66% women) randomly selected from a larger population-based sample enrolled in a longitudinal study of the natural history of insomnia. They completed 12 monthly telephone interviews assessing insomnia, use of sleep aids, stressful life events, and physical and mental health problems in the previous month. A total of 1,125 interviews of a potential 1,200 were completed. Based on data collected at each assessment, participants were classified into one of three subgroups: good sleepers, insomnia symptoms, and insomnia syndrome.
RESULTS: At baseline, 42 participants were classified as good sleepers, 34 met criteria for insomnia symptoms, and 24 for an insomnia syndrome. There were significant fluctuations of insomnia over time, with 66% of the participants changing sleep status at least once over the 12 monthly assessments (51.5% for good sleepers, 59.5% for insomnia syndrome, and 93.4% for insomnia symptoms). Changes of status were more frequent among individuals with insomnia symptoms at baseline (mean = 3.46, SD = 2.36) than among those initially classified as good sleepers (mean = 2.12, SD = 2.70). Among the subgroup with insomnia symptoms at baseline, 88.3% reported improved sleep (i.e., became good sleepers) at least once over the 12 monthly assessments compared to 27.7% whose sleep worsened (i.e., met criteria for an insomnia syndrome) during the same period. Among individuals classified as good sleepers at baseline, risks of developing insomnia symptoms and syndrome over the subsequent months were, respectively, 48.6% and 14.5%. Monthly assessment over an interval of 6 months was found most reliable to estimate incidence rates, while an interval of 3 months proved the most reliable for defining chronic insomnia.
CONCLUSIONS: Monthly assessment of insomnia and sleep patterns revealed significant variability over the course of a 12-month period. These findings highlight the importance for future epidemiological studies of conducting repeated assessment at shorter than the typical yearly interval in order to reliably capture the natural course of insomnia over time.

Entities:  

Keywords:  Insomnia; course; epidemiology; incidence; natural history; persistence

Mesh:

Year:  2014        PMID: 24497660      PMCID: PMC3900620          DOI: 10.5665/sleep.3406

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  33 in total

1.  Validation of the Insomnia Severity Index as an outcome measure for insomnia research.

Authors:  C H. Bastien; A Vallières; C M. Morin
Journal:  Sleep Med       Date:  2001-07       Impact factor: 3.492

2.  The consensus sleep diary: standardizing prospective sleep self-monitoring.

Authors:  Colleen E Carney; Daniel J Buysse; Sonia Ancoli-Israel; Jack D Edinger; Andrew D Krystal; Kenneth L Lichstein; Charles M Morin
Journal:  Sleep       Date:  2012-02-01       Impact factor: 5.849

3.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

4.  Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults.

Authors:  N Breslau; T Roth; L Rosenthal; P Andreski
Journal:  Biol Psychiatry       Date:  1996-03-15       Impact factor: 13.382

5.  Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors.

Authors:  C M Morin; M LeBlanc; M Daley; J P Gregoire; C Mérette
Journal:  Sleep Med       Date:  2006-02-03       Impact factor: 3.492

6.  Prevalence and treatment of insomnia in general practice. A longitudinal study.

Authors:  F Hohagen; K Rink; C Käppler; E Schramm; D Riemann; S Weyerer; M Berger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

7.  The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers.

Authors:  Meagan Daley; Charles M Morin; Mélanie LeBlanc; Jean-Pierre Grégoire; Josée Savard
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

8.  Impaired sleep after bedtime stress and worries.

Authors:  Torbjörn Akerstedt; Göran Kecklund; John Axelsson
Journal:  Biol Psychol       Date:  2007-08-06       Impact factor: 3.251

9.  Epidemiology of insomnia: a longitudinal study in a UK population.

Authors:  Hannah Morphy; Kate M Dunn; Martyn Lewis; Helen F Boardman; Peter R Croft
Journal:  Sleep       Date:  2007-03       Impact factor: 5.849

10.  Role of stress, arousal, and coping skills in primary insomnia.

Authors:  Charles M Morin; Sylvie Rodrigue; Hans Ivers
Journal:  Psychosom Med       Date:  2003 Mar-Apr       Impact factor: 4.312

View more
  11 in total

1.  DSM-5 Insomnia and Short Sleep: Comorbidity Landscape and Racial Disparities.

Authors:  David A Kalmbach; Vivek Pillai; J Todd Arnedt; Christopher L Drake
Journal:  Sleep       Date:  2016-12-01       Impact factor: 5.849

2.  Long-Term Effects of Two Formats of Cognitive Behavioral Therapy for Insomnia Comorbid with Breast Cancer.

Authors:  Josée Savard; Hans Ivers; Marie-Hélène Savard; Charles M Morin
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

3.  Organizational justice and insomnia: a prospective cohort study examining insomnia onset and persistence.

Authors:  Toshio Hayashi; Yuko Odagiri; Tomoko Takamiya; Yumiko Ohya; Shigeru Inoue
Journal:  Int Arch Occup Environ Health       Date:  2016-11-03       Impact factor: 3.015

4.  The nature of stable insomnia phenotypes.

Authors:  Vivek Pillai; Thomas Roth; Christopher L Drake
Journal:  Sleep       Date:  2015-01-01       Impact factor: 5.849

5.  Prevalence and Predictors of Prescription Sleep Aid Use among Individuals with DSM-5 Insomnia: The Role of Hyperarousal.

Authors:  Vivek Pillai; Philip Cheng; David A Kalmbach; Timothy Roehrs; Thomas Roth; Christopher L Drake
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

6.  The Course and Impact of Poststroke Insomnia in Stroke Survivors Aged 18 to 65 Years: Results from the Psychosocial Outcomes In StrokE (POISE) Study
.

Authors:  Nick Glozier; Tom J Moullaali; Børge Sivertsen; Dukyeon Kim; Gillian Mead; Stephen Jan; Qiang Li; Maree L Hackett
Journal:  Cerebrovasc Dis Extra       Date:  2017-02-03

7.  Mechanisms Underlying the Action of Ziziphi Spinosae Semen in the Treatment of Insomnia: A Study Involving Network Pharmacology and Experimental Validation.

Authors:  Zhenhua Bian; Wenming Zhang; Jingyue Tang; Qianqian Fei; Minmin Hu; Xiaowei Chen; Lianlin Su; Chenghao Fei; Chunqin Mao; Huangjin Tong; Xiaohang Yuan; Tulin Lu
Journal:  Front Pharmacol       Date:  2021-12-24       Impact factor: 5.810

Review 8.  Management of Chronic Insomnia Using Cognitive Behavior Therapy for Insomnia (CBT-I) During COVID-19 Pandemic: Does One Shoe Fit All?

Authors:  Arghya Pal; Tanmay Joshi; Aniruddha Basu; Ravi Gupta
Journal:  Sleep Vigil       Date:  2022-03-17

9.  Symptoms of Insomnia and Sleep Duration and Their Association with Incident Strokes: Findings from the Population-Based MONICA/KORA Augsburg Cohort Study.

Authors:  A Katharina Helbig; Doris Stöckl; Margit Heier; Karl-Heinz Ladwig; Christa Meisinger
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

10.  Incidence, Persistence, and Remission Rates of Insomnia Over 5 Years.

Authors:  Charles M Morin; Denise C Jarrin; Hans Ivers; Chantal Mérette; Mélanie LeBlanc; Josée Savard
Journal:  JAMA Netw Open       Date:  2020-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.